SCHEMBL6950322

SCHEMBL6950322

COC(=O)Oc1ccccc1-c1ccc(CBr)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SLC13A5 Q86YT5 1/20 0.44
MME P08473 2/20 0.44
MMEL1 Q495T6 1/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
ITGA4 P13612 7/20 0.42
ITGB1 P05556 6/20 0.42
ITGB7 P26010 2/20 0.41
HTT P42858 3/20 0.40
LMNA P02545 2/20 0.40
RXRA P19793 1/20 0.40
RXRB P28702 1/20 0.40
RXRG P48443 1/20 0.40
ALDH1A1 P00352 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28731478 0.85 ALOX15 (0.42) KDM4ESLC13A5MMEMMEL1PPARG
SCHEMBL7795580 0.85 PTGS2 (0.48) KDM4EHPGDHSD17B10SLC13A5LMNA
SCHEMBL6448663 0.85 SLC13A5 (0.39) SLC13A5PPARGPPARAHTTLMNA
SCHEMBL28731487 0.84 ALOX15 (0.44) KDM4ESLC13A5MMEMMEL1PPARG
SCHEMBL15555970 0.83 SLC6A3 (0.56) KDM4EHPGDHSD17B10PPARGPPARA
SCHEMBL6446385 0.83 RXRA (0.47) KDM4ESLC13A5PPARGPPARAHTT
SCHEMBL9754829 0.83 KDM4E (0.44) KDM4EHPGDHSD17B10ITGA4ITGB1
SCHEMBL28731739 0.83 ALOX15 (0.45) KDM4ESLC13A5MMEMMEL1PPARG
SCHEMBL28731467 0.83 ALOX15 (0.46) KDM4ESLC13A5MMEMMEL1PPARG
SCHEMBL1834873 0.82 KDM4E (0.61) KDM4EHPGDHSD17B10HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0863875-B1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY HOFFMANN LA ROCHE (CH) 2003-06-04 EP disclosed
EP-0505893-B1 Imidazopyridines MERCK PATENT GMBH (DE) 2000-06-21 EP disclosed
EP-0863875-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1998-09-16 EP disclosed
WO-1997009311-A1 NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY F. HOFFMANN-LA ROCHE AG (CH) 1997-03-13 WO disclosed
EP-0657454-A1 Imidazopyridazines being angiotensin II antagonists MERCK PATENT GmbH (DE) 1995-06-14 EP disclosed
EP-0657452-A1 Imidazopyridines MERCK PATENT GmbH (DE) 1995-06-14 EP disclosed
EP-0602521-A1 Imidazopyridines MERCK PATENT GmbH (DE) 1994-06-22 EP disclosed
EP-0591891-A2 Benzimidazole derivatives as Angiotensin II antagonists Dr. Karl Thomae GmbH (DE) 1994-04-13 EP disclosed
EP-0574787-A2 Benzimidazole derivatives as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-12-22 EP disclosed
EP-0574846-A2 Imidazopyridines as angiotensin II antagonistes MERCK PATENT GmbH (DE) 1993-12-22 EP disclosed
EP-0564960-A1 Imidazopyridines as angiotensin II antagonists MERCK PATENT GmbH (DE) 1993-10-13 EP disclosed
EP-0547514-A2 Imidazopyridine derivatives with angiotensin-II antagonist properties MERCK PATENT GmbH (DE) 1993-06-23 EP disclosed
EP-0505893-A1 Imidazopyridines MERCK PATENT GmbH (DE) 1992-09-30 EP disclosed
WO-1991013063-A1 NEW BENZIMIDAZOLE DERIVATIVES, METHOD FOR PREPARING THEM AND THEIR PHARMACEUTICAL USE SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1991-09-05 WO disclosed